Estimating the Lifetime Benefits of Treatments for Heart Failure-Reference-Cited by-同舟云学术

Estimating the Lifetime Benefits of Treatments for Heart Failure

Published:2020-12 Issue:12 Volume:8 Page:984-995
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Ferreira João Pedro,Docherty Kieran F.,Stienen Susan,Jhund Pardeep S.,Claggett Brian L.,Solomon Scott D.,Petrie Mark C.,Gregson John,Pocock Stuart J.,Zannad Faiez,McMurray John J.V.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference9 articles.

1. Regression models and life-tables;Cox;J Royal Stat Soc Series B (Methodological),1972

2. Limitations of hazard ratios in clinical trials;Stensrud;Eur Heart J,2019

3. Restricted mean survival time as a measure to interpret clinical trial results;Kim;JAMA Cardiol,2017

4. On the restricted mean survival time curve in survival analysis;Zhao;Biometrics,2016

5. Estimating the long-term treatment benefits of sacubitril-valsartan;Claggett;N Engl J Med,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms;Scientific Reports;2024-06-12

2. Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed;Journal of Cardiac Failure;2023-12

3. Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials;Diabetes, Obesity and Metabolism;2023-08-14

4. Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial;PLOS ONE;2023-06-08

5. Association of 5α-Reductase Inhibitor Prescription With Bladder Cancer Progression in Males in South Korea;JAMA Network Open;2023-05-16